Franklin Resources
SGP

Franklin Resources’s SpyGlass Pharma SGP Stock Holding History

Franklin Resources’s Portfolio SGP Stock Details SGP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.2M Sell
233,412
-66,588
-22% -$1.44M ﹤0.01% 1584
2026
Q1 		$7.77M Buy
+300,000
New +$8.07M ﹤0.01% 1335

Other funds holding SGP

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources's SGP Position: Q2 2026 in Review

Franklin Resources reduced its SpyGlass Pharma (SGP) stake by 22% in Q2 2026, selling an estimated $1.44M and leaving 233,412 shares worth $5.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1584.

Franklin Resources first reported a position in SGP in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.77M in Q1 2026. 43 funds tracked by Wall St. Rank hold SGP as of Q2 2026.

  • Franklin Resources held 233,412 shares of SpyGlass Pharma worth $5.2M as of Q2 2026.
  • Franklin Resources sold 66,588 SpyGlass Pharma shares in Q2 2026, an estimated $1.44M.
  • SpyGlass Pharma made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1584 holding.
  • Franklin Resources first reported a position in SpyGlass Pharma in Q1 2026 and has held it in 2 quarters since.
  • Franklin Resources's SpyGlass Pharma position peaked at $7.77M in Q1 2026.
  • 43 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.